Share Issue 2024

The subscription period for the Rights Issue ended on May 17, 2024 and the final summary shows that 20 678 415 shares, corresponding to approximately 66.6 percent, were subscribed for by the exercise of subscription rights. In addition, the Company received interest from investors of subscribing an additional 2 364 046 shares without the support of subscription rights, corresponding to approximately 7,6 percent for a total subscription with and without the exercise of subscription rights of 74,2 percent. AlzeCure therefore obtains SEK 39,2 million before issue costs. With this outcome, the company has not had to use the bottom guarantee issued by Formue Nord Markedsneutral A/S.